The story of cancer medicine is multi-threaded. It’s a story of early detection, of surgical removal, of radio- and chemo-therapies, of understanding lifestyle factors, of sequencing and pinpointing genetic factors, and lately of immunotherapies, but instead of one succeeding the other, each overlaps and complements and adds more weapons to the armory, and many of these weapons can be deployed in series or in combination.
In this episode of FutureBites, I’m talking to Dr Ben Stanger about adding three more entire armories.
Dr Ben Stanger is the Hanna Wise Professor in Cancer Research at the University of Pennsylvania Perelman School of Medicine. He’s also Director the Penn Pancreatic Cancer Research Center and a member of half a dozen other prestigious Institutes. What a guy! In addition to his many prestigious academic positions, he still practices AND makes time to write science for a popular audience. We met in his office, and in our half-hour conversation, he shared his optimism for three new frontiers in cancer medicine: the advancement from liquid to solid tumors, the development of mRNA cancer vaccines, and the latest work being undertaken in ‘cancer interception.’
As always, I’ll add a post to the FutureBites page soon with additional thoughts and further reading, as well as a copy of the full interview transcript. Enjoy!
Ben's latest book is From One Cell – a Journey Into Life’s Origins and the Future of Medicine. I've enjoyed every page and thoroughly recommend it.
Learn more about my work as a futurist speaker.
See you in the future!
The story of cancer medicine is multi-threaded. It’s a story of early detection, of surgical removal, of radio- and chemo-therapies, of understanding lifestyle factors, of sequencing and pinpointing genetic factors, and lately of immunotherapies, but instead of one succeeding the other, each overlaps and complements and adds more weapons to the armory, and many of these weapons can be deployed in series or in combination.
In this episode of FutureBites, I’m talking to Dr Ben Stanger about adding three more entire armories.
Dr Ben Stanger is the Hanna Wise Professor in Cancer Research at the University of Pennsylvania Perelman School of Medicine. He’s also Director the Penn Pancreatic Cancer Research Center and a member of half a dozen other prestigious Institutes. What a guy! In addition to his many prestigious academic positions, he still practices AND makes time to write science for a popular audience. We met in his office, and in our half-hour conversation, he shared his optimism for three new frontiers in cancer medicine: the advancement from liquid to solid tumors, the development of mRNA cancer vaccines, and the latest work being undertaken in ‘cancer interception.’
As always, I’ll add a post to the FutureBites page soon with additional thoughts and further reading, as well as a copy of the full interview transcript. Enjoy!
Ben's latest book is From One Cell – a Journey Into Life’s Origins and the Future of Medicine. I've enjoyed every page and thoroughly recommend it.
Learn more about my work as a futurist speaker.
See you in the future!